Safety and Immunogenicity of a Novel Staphylococcus aureus Vaccine: Results from the First Study of the Vaccine Dose Range in Humans

• Published in: Clinical and Vaccine Immunology Vol. 17; no. 12; pp. 1868 - 1874
• Main Authors: Harro, Clayton, Betts, Robert, Orenstein, Walter, Kwak, Eun-Jeong, Greenberg, Howard E, Onorato, Matthew T, Hartzel, Jon, Lipka, Joy, DiNubile, Mark J, Kartsonis, Nicholas
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 01.12.2010; American Society for Microbiology (ASM)
• Subjects: Adjuvants, Immunologic - administration & dosage; Adolescent; Adult; Antibodies, Bacterial - blood; Cation Transport Proteins - immunology; Double-Blind Method; Fatigue - chemically induced; Female; Headache - chemically induced; Humans; Immunoglobulin G - blood; Injections, Intramuscular; Male; Middle Aged; Nausea - chemically induced; Pain - chemically induced; Placebos - administration & dosage; Staphylococcal Vaccines - administration & dosage; Staphylococcal Vaccines - adverse effects; Staphylococcal Vaccines - immunology; Staphylococcus aureus; Staphylococcus aureus - immunology; Vaccine Research; Young Adult
• ISSN: 1556-6811; 1556-679X; 1556-679X
• DOI: 10.1128/CVI.00356-10

Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy CVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 1556-6811 Online ISSN: 1556-679X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to CVI .asm.org, visit: CVI